NIFTY  9,609.50  0.05%
  SENSEX  31,132.80  0.08%
 CURRENCY  Rs  64.50/$ 71.76/€, 82.64/£
  GOLD  28,945.00  0.16%
  SILVER  40,410.00  0.18%
  DAX  12,629.00  0.21%
  FTSE  7,547.63  0.40%
  CAC  5,332.47  -0.07%
  HANG SENG  25,701.60  0.24%
  NIKKEI  19,682.60  -0.02%
  Shanghai Composite  3,110.06  0.04%
  DOW JONES  21,080.30  -0.01%
  NASDAQ  6,210.19  0.08%
  S&P 500  2,415.82  0.03%
EARNINGS REPORT - Lincoln Pharma Consol Total Income At Rs 120 Cr Vs Rs 129 Cr YoY EARNINGS REPORT - Lincoln Pharma Q4 Consol PAT At Rs 98 Lk Vs Rs 4 Cr YoY

TCS Q2 Results Beat Street Estimates

Video:

Play this video

October 15: TCS’ bottomline rose 22%, exceeding market expectations, helped by a 11% weakening in the rupee. The operating margins were at an all-time high of 30.2% against expectations of 29%. The TCS management seemed positive on the earnings, with all geographical regions performing well. Watch this segment to hear the management’s views and get a breakdown of the company results.